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A BS T R A CT    
 
 
The present study aimed to develop a pre-endothelialized chitosan (CH) porous hollowed scaffold for 
application in spinal cord regenerative therapies. CH conduits with different degrees  of  acetylation 
(DA; 4% and 15%) were prepared, characterized (microstructure, porosity and water uptake) and func- 
 tionalized with  a  recombinant  fragment of  human ﬁbronectin  (rhFNIII ).  Immobilized rhFNIII 
 7–10 7–10 
was characterized in terms of amount (125I-radiolabelling), exposure of cell-binding domains (immuno- 
ﬂuorescence) and ability to mediate endothelial cell (EC) adhesion and cytoskeletal rearrangement. Func- 
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and, for the same concentration, higher amounts of rhFNIII7–10  on DA 4% compared with DA 15%. More- 
over, rhFNIII7–10  concentrations as low as 5 and 20 lg ml-1  in the coupling reaction were shown to pro- 
vide DA 4% and 15% scaffolds, respectively, with levels of exposed cell-binding domains exceeding those 
observed on the control (DA 4% scaffolds incubated in a 20 lg ml-1  human ﬁbronectin solution). These 
grafting conditions proved to be effective in mediating EC adhesion/cytoskeletal organization on CH with 
DA 4% and 15%, without affecting the endothelial angiogenic potential. rhFNIII7–10 grafting to CH could be 
a strategy of particular interest in tissue engineering applications requiring the use of endothelialized 
porous matrices with tunable degradation rates. 
 
  
 
1. Introduction 
 
Spinal cord injury (SCI) is a devastating condition, leading often 
to persistent loss of sensory, motor and autonomic function below 
the site of injury. Following SCI, neural and vascular structures are 
disrupted, and a series of complex events occur, including inﬂam- 
mation and disruption of the blood/spinal cord barrier, leading to 
progressive cell death, demyelination and enlargement of the dam- 
aged area culminating in the formation of a glial scar [1]. In pre- 
clinical studies, improved functional recovery after SCI has been 
achieved through the use of therapies focused on stem cell trans- 
plantation, delivery of neurotrophic factors, antagonism of neu- 
rite-outgrowth inhibitors, modulation of the inﬂammatory 
response, and use of bridging support matrices [2–4].   However, 
 
 
 
to achieve bridging axonal regeneration and full functional recov- 
ery, combinations of complementary and synergistic therapeutic 
approaches integrating guidance matrices, cells and localized 
delivery of therapeutic molecules are likely to be required [3,4]. 
The use of single and multi-channelled nerve guidance tubes to 
bridge the cystic cavity formed following SCI contributes in differ- 
ent ways to the establishment of a more permissible microenviron- 
ment for axonal regeneration. Besides providing mechanical 
support for the lesion area and protecting it from the inﬁltration 
of inﬂammatory cells, they concentrate neurite-growth-promoting 
factors released from the severed nerve stumps, while also guiding 
axonal growth through intra luminal architecture [4]. Moreover, 
hydrogels containing cell suspensions and/or signalling molecules 
may be easily incorporated in their inner lumen [5,6]. These inter- 
nal hydrogel matrices allow homogeneous cell distribution and 
provide physical support for axonal growth, apart from helping 
to sequester cell-secreted growth factors and preventing channel 
collapse [4]. 
The present study aimed to develop a pre-endothelialized chito- 
san (CH) porous hollowed scaffold for application in spinal   cord 
 
  
regenerative therapies. CH biodegradability and cytocompatibility 
with neural cells [7] associated with its versatility to be processed 
into ﬂexible tubular and porous structures make it interesting for 
the design of guidance matrices. CH-based nerve guidance matri- 
ces have been successfully explored for peripheral nerve regenera- 
tion [8] and, more recently, for application in the spinal cord, in 
combination with cell transplantation therapies [9–11]. CH degra- 
dation in vivo is thought to be mediated predominantly by lyso- 
zyme [12], an enzyme normally present in the cerebrospinal ﬂuid 
at low concentrations, though upregulated after SCI [13,14]. The 
susceptibility of CH to lysozyme-mediated degradation is directly 
inﬂuenced by its degree of acetylation (DA) [15], with  higher 
DAs leading to faster degradation rates in vivo [16]. CH degradation 
can, therefore, be tuned by varying the DA. The effect of DA on CH 
degradation proﬁle in the spinal cord was investigated recently in 
non-immunosuppressed rats, using non-porous CH matrices with 
DA 15% and 22% [17]. Even though both matrices were considered 
suitable for long-term spinal cord applications, DA 15% implants 
were shown to elicit a weaker inﬂammatory response. However, 
with respect to CH porous structures, the range of DA adequate 
for this application is still an issue to be addressed. 
Endothelialization of guidance matrices is a novel approach in 
the context of SCI therapies. Apart from secreting trophic factors 
[18] that may contribute per se to create a more favourable envi- 
ronment for regeneration, endothelial cells (ECs) are expected to 
contribute to angiogenesis in vivo and, hopefully, to the establish- 
ment of a functional microvascular network upon implantation. 
Both effects will be important to enhance the survival of co-trans- 
planted cells, such as mesenchymal stem or neural progenitor cells, 
which in  turn may contribute to vessel stabilization   [19]. 
Previous work showed that colonization of CH scaffolds by EC 
could be achieved by  physically  adsorbing  human ﬁbronectin 
(hFN) to CH [20], the most frequent approach to promoting EC 
adhesion to polymeric biomaterials [21]. Nevertheless, the effec- 
tiveness of hFN physiadsorption in mediating EC adhesion to CH 
was found to be strongly dependent on  the  DA.  More precisely, 
hFN physiadsorption was only effective in promoting cell adhesion 
to CH with a low DA (4%) and not to CH with DA 15%, which, de- 
spite its poorer cell adhesive properties may also be an interesting 
polymer for the application in view, as it presents a faster degrada- 
tion rate. Besides developing CH porous tubular scaffolds for use in 
SCI therapies, this work explored a strategy to promote EC adhe- 
sion to CH with different DAs. This was pursued by covalently 
binding to CH scaffolds, a recombinant fragment of hFN, rhFN III7–
10, which includes the arginine–glycine–aspartic acid (RGD) 
integrin-binding motif of the 10th type III repeat and the pro- line–
histidine–serine–arginine–asparagine (PHSRN) synergy site 
domain on the 9th type III repeat   [22]. 
 
2. Materials and methods 
 
2.1. CH puriﬁcation and characterization 
 
Squid pen CH (Batch No. 171204; DA 1.5%) was supplied by 
France Chitine and, subsequently, puriﬁed by ﬁltration of CH acidic 
solution, followed by alkali precipitation. The puriﬁed CH was 
characterized in terms of DA and average molecular weight by Fou- 
rier transform infrared spectroscopy (FTIR) and size exclusion 
chromatography, respectively, as previously described [20]. A   DA 
of   3.55 ± 0.32%,   with   weight-average   molecular   weight    (Mw) 
5.0 ± 0.2 x 105 and polydispersity index (PDI) 1.8 ± 0.1 were found. 
CH with DA rv15% was prepared by N-acetylation of the puriﬁed CH 
according to Vachoud et al. [23]. Subsequent analysis revealed a DA 
of 15.35 ± 1.26, Mw 4.3 ± 0.1 x 10
5 and a PDI of 2.2 ± 0.1. Endotoxin 
levels were measured in water extracts using the Limulus Amebo- 
cyte Lysate Assay (QCL-1000, Cambrex). The two polymers   re- 
vealed   endotoxin   levels   <0.1 EU ml-1,   respecting   the   US 
Department of Health and Human Services guidelines for implant- 
able devices [24]. 
 
2.2. Preparation and characterization of CH cylindrical hollowed 
porous scaffolds 
 
CH  porous  conduits  with  a  porous  luminal  surface  were  pre- 
pared from degassed 2% w/v CH solutions in 0.2 M acetic acid solu- 
tion   by   thermally   induced   phase   separation   (-80 °C)   and 
subsequent sublimation of ice crystals. Poly(vinyl chloride) (PVC) 
tubes  (25 mm  in  length;  Øext = 6.08 mm;  Øint = 3.85 mm)  with  a 
plastic  wire  (Ø = 1.83 mm)  inserted  in  the  inner  part  were  used 
as moulds. Following lyophilization (-86 °C; 0.2 mbar), the exter- 
nal PVC mould was removed, and the resultant scaffolds sequen- 
tially  immersed  in  serially  diluted  ethanol  solutions  and  ﬁnally 
Milli-Q ultrapure water (Millipore), to eliminate acid. The internal 
wire was then removed, and the scaffolds lyophilized once again. 
The resultant porous  conduits were  cut into  sections  4 mm long 
and characterized in terms of microstructure, porosity and water 
uptake.  For  microstructure  analysis,  the  scaffolds  were  trimmed 
in liquid nitrogen into transversal and longitudinal cross sections, 
lyophilized  and,  ﬁnally,  sputter-coated  with  gold  before  being 
examined  by  scanning  electron  microscopy  (SEM).  The  average 
pore diameter and diameter of interconnecting pores were deter- 
mined as previously described [20], analyzing 20 SEM images corre- 
sponding  to  transversal  cross  sections  of  at  least  three  different 
samples. Porosity was assessed using the liquid displacement meth- 
od, using absolute ethanol as the displacement liquid [25]. Prior to 
the analysis, samples were dried in a vacuum oven at 30 °C for 24 h 
and longitudinally sectioned. For each measurement, two scaffolds 
(9–12 mg)  were  used.  For  water  uptake  measurements,  samples 
were dried, longitudinally sectioned, and then immersed in ultra- 
pure water for 24 h at room temperature (RT). Prior to being used 
in the subsequent assays, the scaffolds were sterilized in 70% etha- 
nol v/v and equilibrated in sterile phosphate-buffered saline (PBS). 
 
2.3. Expression and puriﬁcation of rhFNIII7–10 
 
The prokaryotic expression vector pET-15b with an insert coding 
for  rhFNIII7–10   (pET-15b–rhFNIII7–10)  was  kindly  provided  by  Dr. 
Harold  P.  Erickson  (Duke  University  Medical  Center).  rhFNIII7–10 
was expressed in BL21(DE3) Escherichia coli transformed with the 
pET-15b–rhFNIII7–10  plasmid, as described by Aukhil et al. [26]. So- 
dium  dodecyl  sulphate-polyacrylamide  gel  electrophoresis  (SDS- 
PAGE) was used to check the presence of rhFNIII7–10  in the soluble 
extract of bacterial lysates. rhFNIII7–10 was puriﬁed by afﬁnity chro- 
matography (1 ml Bio-Scale Mini IMAC cartridge charged with Ni2+; 
Bio-Rad) followed by buffer exchange to 20 mM Tris–HCl, pH 7.4 
and ion exchange chromatography (1 ml HiTrap Q HP column, GE 
Healthcare) [27]. Following elution with a 0–500 mM NaCl gradient 
over 20 column volumes, puriﬁed rhFNIII7–10  was dialyzed against 
20 mM Tris–HCl pH 7.9 and its purity analysed by SDS-PAGE under 
reducing conditions. The purity of each fraction was determined by 
densitometry  analysis,  while  the  molecular  weight  was  interpo- 
lated from a standard curve obtained by plotting the log10  of the 
molecular weight of the standard proteins vs. their relative mobility 
[28]. Puriﬁed rhFNIII7–10  was characterized in terms of protein con- 
centration  (DC  Protein  Assay,  Bio-Rad),  ﬂash  frozen  and  ﬁnally 
stored  at  -80 °C.  Before  use,  the  protein  aliquots  were  rapidly 
thawed, spun down and the concentration determined. 
 
2.4. Immobilization of rhFNIII7–10 
 
Immobilization of rhFNIII7–10 was performed using carbodiim- 
ide chemistry and 0.1 M 2-morpholinoethanesulfonic acid (MES) 
  
buffer (pH 6.5). CH scaffolds were equilibrated in 0.1 M MES for 1 h 
under reduced pressure and then transferred to rhFNIII7–10 solu- 
tions  in  0.1 M  MES  with  concentrations  ranging  from  2.5 to 
80 lg ml-1.  After  15 min,  N,N-(3-dimethylaminopropyl)-N-ethyl 
carbodiimide (EDC) and N-hydroxysuccinimide (NHS), previously 
dissolved in 0.1 M MES were added. EDC was added at 1 mol mol-1 
of carboxilate moieties present in rhFNIII7–10, and NHS was added 
at a molar ratio of 1:2 to EDC. Grafting was carried for 15 h at 37 °C 
in a thermostat-regulated orbital shaker (250 rpm), using 60 ll of 
rhFNIII7–10 solution/scaffold. At the end of this period and to re- 
move rhFNIII7–10 electrostatically bound to the CH amine groups 
positively charged at pH 6.5 [29], scaffolds were incubated in PBS 
with pH 8.5 for 1 h. Finally, the samples were rinsed and squeezed 
(3x) in PBS. Physiadsorption of rhFNIII7–10 was performed in paral- 
lel for comparison purposes, incubating the scaffolds in rhFNIII7–10 
solutions (2.5 to 80 lg ml-1) in PBS for 15 h (37 °C; 250 rpm). CH 
scaffolds (DA 4%) incubated for 15 h in a 20 lg ml-1  hFN (Sigma) 
solution in PBS were used as controls. 
 
2.5. Characterization of CH porous conduits grafted with rhFNIII7–10 
 
 
2.5.1. FTIR with attenuated total reﬂectance 
The IR spectra were obtained with an FT-IR system 2000 (Per- 
kin-Elmer) using the SplitPea™ accessory (Harrick Scientiﬁc) after 
accumulation  of  200  interferograms  at  a  4 cm-1   spectral  resolu- 
tion. Prior to analysis, the scaffolds were dried at 60 °C in a vacuum 
oven for 12 h. All spectra were corrected for the attenuated total 
reﬂectance (ATR) characteristic progressive increase in the absor- 
bance at lower wave numbers, using the equipment software. 
 
2.5.2. 125I-radiolabelling 
The amount of rhFNIII7–10  incorporated into CH was quantiﬁed 
using 125I-rhFNIII7–10  as a tracer molecule. rhFNIII7–10  was labelled 
as previously described [30]. Fractions with yield of 125I-labelling 
P98.8%  were  used.  The  labelled  fragment  was  stored  at  -20 °C 
and used within 2 days. Prior to the grafting reaction, CH scaffolds 
were individually weighted, sterilized and hydrated as described 
above,  and  equilibrated  overnight  in  degassed  PBS  with  0.01 M 
NaI, to prevent adsorption of free 125I ions present in trace amounts 
in 125I-rhFNIII7–10. To assess whether preferential grafting of 
125I- 
labelled rhFNIII7–10  or unlabelled rhFNIII7–10  occurred, a series of 
control experiments were initially performed, varying the ratio of 
labelled  to  unlabelled  rhFNIII7–10.  In  all  the  subsequent  grafting 
reactions,  labelled  solutions  with  a  ﬁnal  activity  of  rv4 x 106 - 
cpm ml-1    were   used.   Functionalized   samples   were   processed 
straight  away  for  gamma  activity  counting  or  further  incubated 
in 200 ll of the serum-containing medium used in cell culture as- 
says for 24 h, to assess the amount of immobilized rhFNIII7–10 re- 
tained in the presence of serum proteins. Prior to gamma activity 
counting, all samples were sequentially rinsed and  squeezed  in 
PBS (8x), immersed in PBS for 15 h at RT, and rinsed again in 
PBS (3x) to  remove  unbound  rhFNIII7–10.  Fibronectin adsorption 
to CH was determined as previously described, using 125I-hFN  [20]. 
 
2.5.3. Exposure of cell-binding domains 
The distribution and bioactivity of immobilized rhFNIII7–10 was 
assessed by immunoﬂuorescent staining of cell-binding domains. 
Three scaffolds per condition were ﬂash frozen in liquid nitrogen 
and cryosectioned to yield transversal sections 100 lm thick. Sam- 
ples were incubated with 1% w/v heat-denatured bovine serum 
(BSA) in PBS and then for 1 h with mouse monoclonal HFN 7.1 
(Developmental Studies Hybridoma Bank) diluted to 1:1000. 
Detection   was   achieved   with   Alexaﬂuor   568-conjugated  anti- 
mouse  IgG  (Molecular  Probes)  diluted  at  5 lg ml-1.  After  being 
rinsed, samples were mounted with Fluoromount (Sigma) for con- 
focal laser scanning microscopy (CLSM) imaging or transferred to 
the wells of 24-well tissue culture polystyrene plates, for quantita- 
tive analysis of ﬂuorescence intensity (FI). The FI of each cryosec- 
tion was read (kEx 578 nm;  kEm 603 nm)  using  a  BioTek
® 
Synergy™ MX plate reader with the optics position set to bottom. 
The FI values were determined by subtracting the FI value of sam- 
ples incubated in 0.1 M MES without rhFNIII7–10. 
 
2.6. EC behaviour in porous conduits grafted with rhFNIII7–10 
 
 
2.6.1. Cell culture 
A cell line of human pulmonary microvascular endothelial cells 
(HPMEC-ST1.6R cell line) displaying most of the major constitu- 
tively expressed and inducible endothelial phenotypic markers 
was used [31]. Cells were cultured in complete culture media 
(CCM) containing 20% (v/v) fetal bovine serum, as previously de- 
scribed [20]. 
 
2.6.2. Cell seeding 
For cell  adhesion  and  cytoskeleton organization studies,  longi- 
tudinally  sectioned  porous  conduits  (hemi  sections)  were  used. 
Cell  seeding  was  performed  by  adding  9 ll  of  a  cell  suspension 
(3 x 106 cells ml-1  in CCM) to the luminal surface of the scaffolds. 
After  a  3 h  incubation  period  at  37 °C,  the  scaffolds  were  trans- 
ferred to the wells of 48-well suspension culture plates (Cellstar®, 
Greiner Bio-one) and 500 ll of CCM were added. For the in vitro 
angiogenesis studies, EC were seeded in the lumen of the tubular 
scaffolds, using a two-step process. Initially, 2 x 10 ll of a cell sus- 
pension (3 x 106 cells ml-1  in CCM) were transferred to the lumen 
of the internal channel. After 3 h incubation at 37 °C, the scaffolds 
were  rotated  manually  180°,  and  the  cell  seeding  procedure  re- 
peated, to ensure the homogeneous cell seeding of the luminal sur- 
face.  Following  a  second  incubation  period  of  3 h  at  37 °C,  the 
scaffolds were transferred to the wells of 48-well suspension cul- 
ture plates, and 1 ml of CCM was added. The cell constructs were 
cultured for periods of up to 5 days, the medium being refreshed 
every other day. 
 
2.6.3. Cell adhesion 
Cell adhesion was inferred from cell metabolic activity, deter- 
mined as described previously [20], 24 h after cell seeding using 
a    resazurin-based    assay.    Fluorescence    was    measured   (kEx 
530 nm; kEm  590 nm), and the ﬂuorescence value   corresponding 
to unseeded scaffolds subtracted. The cell number was extrapo- 
lated from a standard curve, where ﬂuorescence was plotted 
against a known number of HPMECs seeded in parallel on hFN- 
coated wells and further incubated for 2 h to allow for cell 
adhesion. 
 
2.6.4. Cytoskeletal organization 
Cytoskeletal organization was assessed 24 h after cell seeding 
by F-actin/DNA ﬂuorescent labelling, as described previously   [32]. 
 
2.6.5. Angiogenic potential 
The angiogenic potential of HPMEC-ST1.6R cells seeded on rhF- 
NIII7–10-grafted CH scaffolds was investigated after 5 days of cell 
culture by adding a ﬁbrin gel to the EC-colonized scaffolds and cul- 
turing these in the presence of angiogenic stimuli. For this purpose, 
a ﬁbrin gel was prepared by polymerization of ﬁbrinogen in   the 
presence of thrombin and CaCl2  (ﬁnal concentration in the poly- 
merizing solution: 6 mg ml-1 plasminogen-free human ﬁbrinogen; 
2 NIH U ml-1  thrombin; 2.5 mM CaCl2, all Sigma). The polymeriz- 
ing ﬁbrin gel (20 ll) was injected into the inner lumen of the por- 
ous conduits and the cell–matrix constructs incubated at 37 °C for 
30 min to allow gel polymerization. At the end of this period, 1 ml 
  
of   CCM   supplemented   with   25 ng ml-1    of   VEGF   (Milllipore), 
10 ng ml-1   of  bFGF  (Prepotech)  and  5 lg ml-1   aprotinin  (Sigma) 
was added to each EC-colonized scaffold, and the cells were cul- 
tured for an additional period of 48 h. To assess EC sprouting into 
the ﬁbrin gel, samples were ﬁxed in 3.7% PFA, embedded in gelatin, 
frozen in liquid nitrogen, cryosectioned at 100 lm thickness, and 
further processed for hematoxylin and eosin (H&E) staining. For 
live imaging of EC sprouting under CLSM, EC-colonized longitudi- 
nal hemisections of the porous scaffolds were embedded in  the 
ﬁbrin gel, and cultured as described above. After 48 h of cell cul- 
ture, the cell–matrix constructs were incubated with calcein AM 
(4 lM; 37 °C; 30 min) and further with propidium iodide (6 lM; 
37 °C; 10 min), for detection of viable and non-viable cells, 
respectively. 
 
2.7. Statistical analysis 
 
Reported values are the mean ± standard deviation. Sample dis- 
tribution was tested for normality using the Kolmogorov–Smirnov 
test, and data subsequently analysed using the unpaired t-test. A 
95% conﬁdence level was considered statistically signiﬁcant. Calcu- 
lations were performed using IBM®  SPSS®  Statistics (version  19). 
 
3. Results 
 
3.1. Characterization of CH porous scaffolds 
 
The moulding system described yielded porous conduits with 
reproducible size and  structure,  with  inner  and  outer diameters 
of 1.8 and 3.6 mm, respectively. SEM analysis revealed outer and 
luminal surfaces of the conduits with open porosity and no evi- 
dence of skin formation (Fig. 1). At higher magniﬁcation, cross sec- 
tions showed a highly porous and interconnected homogeneous 
microstructure, as well as the presence of round oriﬁces in the thin 
polymeric walls delimiting the pores, corresponding to intercon- 
necting pores (Fig. 1b and e). Subsequent image analysis of trans- 
versal cross sections further revealed values of pore diameter in 
the  range  45–78 lm,  and  higher  average  pore  diameter  for  DA 
15% (p < 0.001, Table 1). In terms of interconnective pores, similar 
values of average diameter were found for the two types of scaf- 
folds, namely in the range 22–24 lm (Table 1). In agreement with 
SEM results, porosity analysis revealed high values of porosity for 
both the DAs investigated (98.3%). Following immersion in water 
for 24 h, the lyophilized scaffolds absorbed more than 3400% of 
their initial weight, showing no apparent change in microstructure, 
as demonstrated by subsequent CLSM imaging of the hydrated 
samples (Fig. S1). As higher water uptake values  were found  for 
DA 15% compared with DA 4% (p = 0.001), water uptake measure- 
ments were also performed in CH ﬁlms prepared from the same 
polymers (1% w/v in 0.2 M CH3COOH). Results also revealed higher 
water uptake levels for DA 15% (233 ± 7%) compared with DA 4% 
(196 ± 6%). 
 
3.2. rhFNIII7–10 expression and puriﬁcation 
 
Elution of puriﬁed rhFNIII7–10 was observed when an ionic 
strength of about 20 mS (rv200 mM NaCl) was used. Subsequent 
analysis of coomassie blue-stained SDS-PAGE gel of the eluted 
chromatography fractions (Fig. S2) of the puriﬁed fragment re- 
vealed a purity ranging from 96.1% to 97.3% and a molecular 
weight of 43.85 kDa, which is close to the molecular weight calcu- 
lated from the amino acid sequence of this fragment (41.66 kDa) 
[27]. 
 
3.3. EC behaviour on CH porous conduits physiadsorbed with rhFNIII7–10 
 
To enable EC adhesion to CH, physiadsorption of rhFNIII7–10 was 
initially explored. For this purpose, HPMEC-ST1.6R cells were 
seeded  on  CH  porous  conduits  previously  incubated  with    rhF- 
NIII7–10   (2.5–80 lg ml-1),  and  the  cytoskeleton  of  adhered  cells 
investigated after 24 h of cell culture. Results showed that, in the 
case   of   DA   4%,   rhFNIII7–10     concentrations   P20 lg ml-1     of 
rhFNIII7–10   were  as  effective  as  hFN  (20 lg ml-1)  in  allowing  EC 
cytoskeletal organization  and scaffold colonization  (Fig. 2a, c   and 
 
 
  
 
 
  
 
 
Fig. 1.  SEM micrographs of dehydrated CH cylindrical hollowed porous scaffolds (DA 4% and 15%). Transversal (a, b, d, e) and longitudinal cross-sections (c and f) are shown. 
(b and e) depicts high magniﬁcation SEM micrographs, showing the presence of interconnecting pores (⁄) in the thin polymeric walls. 
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Table 1 
Characterization of CH cylindrical hollowed porous scaffolds in terms of average pore diameter (mean ± SD; n = 70), average diameter of 
interconnecting pores (mean ± SD; n = 70), porosity (mean ± SD; n = 3), and water uptake (mean ± SD; n = 5). 
 
DA (%) Average pore diameter (lm) Average diameter of interconnecting pores (lm) Porosity (%) Water uptake (%) 
4 55.57 ± 10.41
*
 22.19 ± 8.15 98.3 ± 0.0 3449.4 ± 83.4
*
 
15 64.07 ± 13.71 23.94 ± 8.34 98.3 ± 0.0 3752.4 ± 115.1 
*   p 6 0.001 vs. DA 15%. 
 
e). However, in the case of DA 15%, the simple adsorption of rhF- 
NIII7–10 to the scaffolds was not sufﬁcient to permit EC adhesion 
and cytoskeletal organization on CH, regardless of the rhFNIII7–10 
concentration used (Fig. 2d). In fact, most of the few ECs that re- 
mained attached to the scaffolds displayed a round-shaped mor- 
phology with faint F-actin staining, behaving similarly to ECs 
seeded on CH porous conduits merely incubated in CCM (Fig.   S3). 
Only in the case of incubation of DA 15% scaffolds with 80 lg ml-1 
of rhFNIII7–10 was a modest improvement in EC adhesion and 
spreading observed (Fig. 2f), in the range of that provided by pas- 
sively adsorbed hFN (Fig. 2b). 
To provide an insight into the marked differences observed be- 
tween the two DAs in terms of EC response to physiadsorbed rhF- 
NIII7–10, protein adsorption studies were performed. Radiolabelling 
assays using a range of 125I-labelled rhFNIII7–10  solutions    (0.5– 
80 lg ml-1) showed a linear increase in the adsorbed rhFNIII7–10 
3.4. Immobilization of rhFNIII7–10 onto CH porous conduits 
 
As an alternative strategy to protein physiadsorption, the cova- 
lent binding of rhFNIII7–10 to CH scaffold surface was addressed. To 
evaluate  the  effectiveness  of  EDC/NHS  mediated  amidation, CH 
scaffolds (DA 4%) were functionalized with rhFNIII7–10 (80 lg ml-1) 
in the absence or presence of EDC/NHS, and immobilized 
rhFNIII7–10 detected by immunoﬂuorescent labelling of FN cell- 
binding domains. Results revealed 12-fold higher FI levels follow- 
ing incubation in the presence of EDC/NHS compared with 0.1 M 
MES alone (Fig. S6). 
 
3.4.1. ATR-FTIR spectroscopy 
ATR-FTIR analysis was performed to study the nature of the 
coupling reaction. The ATR-FTIR spectra of functionalized CH scaf- 
folds, as well as of the unmodiﬁed scaffolds, are presented in Fig. 3. 
with increasing rhFNIII7–10  concentration  (R
2 = 0.9932) and,  for The covalent binding of  rhFNIII7–10 to CH primary amines is   sup- 
the same concentration (20 lg ml-1), threefold lower amounts of 
adsorbed rhFNIII7–10 on DA 15% compared with DA 4% (Fig. S4a 
and b). In line with these results, for the same rhFNIII7–10 input 
concentration, lower numbers of exposed  cell-binding  domains 
were   found   on   DA   15%   scaffolds   compared   with   DA    4% 
(p < 0.001; Fig. S5). 
ported by the decrease in the peak at 1585 cm-1  assigned to the 
N–H  deformation  in  amines  [33].  The  decrease  in  the  peaks  at 
1070 and 1032 cm-1  (C–O stretching and C–N stretching in >CH– 
NH2  [33–35]) further conﬁrms the grafting of rhFNIII7–10  at the ex- 
pense of CH primary amines. Spectrum analysis also revealed an 
increase in the Amide I peak (C@O stretching in primary amides) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.  Fluorescent labelling of F-actin (green) and DNA (red) of HPMEC-ST1. 6R cells cultured on CH porous conduits (DA 4% and 15%) previously incubated in a 20 lg ml-1 
hFN solution (a and b) or in rhFNIII7–10 solutions with concentrations of 20 (c and d) and 80 lg ml-1 (e and f). Images obtained by CLSM, 24 h after cell seeding. The polymeric 
structure is shown in blue due to CH autoﬂuorescence upon excitation by the 405 nm laser. 
 Unmodified CH 
CH grafted with rhFNIII7-10 
 
amounts of rhFNIII7–10 compared with DA 4% (Fig. 4b). Following 
subsequent incubation of the functionalized scaffolds in serum-
containing medium for 24 h, partial elution of immobilized 
rhFNIII7–10 occurred. Nevertheless, as expected, immobilized rhF- 
NIII7–10 showed higher retention in the presence of competitive 
proteins than physiadsorbed hFN, in the case of both DA 4% and 
DA 15% scaffolds (1.5- and 1.7-fold higher, respectively). 
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3.4.3. Exposure of cell-binding domains 
The distribution and conformation of rhFNIII7–10 upon grafting 
to CH were examined by immunoﬂuorescent staining of cell- 
binding domains on cryosections (Fig. 5). For this purpose, the 
monoclonal HFN7.1 antibody that binds to the major cell-binding 
domain of hFN between the ninth and tenth type III repeat was 
Wave number (cm-1) 
 
Fig.  3.  ATR–FTIR  spectra  (1800–800 cm
-1
)  of  CH  porous  conduits  grafted  with 
rhFNIII7–10   (80 lg ml-1;  solid  line)  and  unmodiﬁed  CH  porous  conduits  (dotted 
line). Spectra shown correspond to CH porous conduits with DA 4%. 
used. This antibody has proved to be an effective probe for measur- 
ing FN functionality following adsorption onto different substrates, 
namely in terms of exposure of integrin binding sites [36]. Covalent 
binding of rhFNIII7–10 resulted in a homogeneous distribution of 
rhFNIII7–10  with  exposure  of  cell-binding  domains,  as  shown  by 
CLSM (Fig. 5a). Subsequent ﬂuorimetry analysis revealed an in- 
at  1648 cm-1,  possibly  due  to  the  contribution  of  amide  bonds crease in FI levels with increasing   rhFNIII7–10 concentration  and, 
from rhFNIII7–10  to the amide I vibration. Moreover, the increase 
in Amide I peak intensity is also in accordance with the 
establishment of amide linkages between carboxylate moieties of 
rhFNIII7–10  and CH amine groups. 
in the case of DA 4%, a saturation plateau reached at 20 lg ml-1 
(Fig.  5b).  In  line  with  radioiodination  results,  DA  4%  scaffolds 
showed signiﬁcantly higher FI levels than DA 15%, regardless of 
the   rhFNIII7–10     concentration   used,   except   for   the     highest 
concentration  tested  (80 lg ml-1).  Moreover,  while  for  DA  4%, 
1 
3.4.2. Radioiodination assays rhFNIII7–10  concentrations  as  low  as  5 lg ml
-
 were sufﬁcient to 
First, the effect of 125I-labelled rhFNIII7–10 on the grafting of rhF- 
NIII7–10 to CH was assessed. As no correlation between the ratio 
125I-rhFNIII7–10/rhFNIII7–10 used and the amount of immobilized 
rhFNIII7–10 was found, 
125I-labelled rhFNIII7–10 was used as a tracer 
to quantify rhFNIII7–10 grafting to CH (Fig. S7). The results showed a 
linear increase of immobilized rhFNIII7–10 amounts with increasing 
rhFNIII7–10 concentration (R
2 = 0.9914), within the range of concen- 
trations tested (Fig. 4a). Moreover, when the amounts of immobi- 
lized rhFNIII7–10  are compared with those of passively  adsorbed 
hFN, for the same input protein concentration (20 lg ml-1), cova- 
lent binding was found to provide CH with higher amounts of pro- 
tein (1.6- and 3.4-fold higher for DA 4% and 15%, respectively). 
Nevertheless, the DA was found to inﬂuence the levels of immobi- 
lized rhFNIII7–10 on CH, DA 15% scaffolds revealing 2.5-fold lower 
provide CH conduits with levels of exposed cell-binding domains 
exceeding those provided by passively adsorbed hFN (20 lg ml-1, 
control),  for  DA  15%,  similar  levels  were  only  attained  using 
20 lg ml-1  of rhFNIII7–10. 
 
3.5. EC behaviour in porous conduits grafted with rhFNIII7–10 
 
The ability of immobilized rhFNIII7–10 to mediate EC adhesion to 
CH was subsequently investigated, and compared with that of pas- 
sively adsorbed hFN. Immobilized rhFNIII7–10  was shown to be    as 
effective as  passively  adsorbed  hFN  (20 lg ml-1,  control)  in  pro- 
moting  EC  adhesion  to  DA  4%,  for  rhFNIII7–10   concentrations  as 
low  as  5 lg ml-1   (Fig.  6a).  Most  importantly,  immobilized  rhF- 
NIII7–10  allowed  the  attainment  of  similar  cell  numbers  on   DA 
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Fig. 4.  Quantitation of immobilized rhFNIII7–10 on CH porous conduits, as determined using 
125
I-labelled rhFNIII7–10 (mean ± SD; n = 8). (a) Immobilized amount of rhFNIII7–10 
on DA 4% conduits as a function of rhFNIII7–10 input concentration. (b) Immobilized amount of rhFNIII7–10 on CH porous conduits (DA 4% and 15%) using a 20 lg ml-1 rhFNIII7– 
10  input concentration as well as their retention after further incubation in the serum-containing culture medium used in cell culture assays (CCM) for 24 h. The levels of FN 
adsorption from a 20 lg ml-1  hFN solution and their retention following incubation in CCM are also shown. ⁄p < 0.001. 
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Fig. 5.  Distribution and conformation of rhFNIII7–10  upon grafting to CH porous conduits (DA 4% and 15%), as probed by immunoﬂuorescent staining of the integrin-binding 
RGD site of FN in cryosections (in red). (a) CLSM imaging of CH scaffolds (DA 4%) grafted with rhFNIII7–10  (20 lg ml-1). (b) Quantitative analysis of exposed cell-binding 
domains  as  a  function  of  rhFNIII7–10  input  concentration,  as  determined  by  ﬂuorimetry  (mean ± SD;  n = 9).  The  dotted  line  indicates  the  levels  of  exposed  cell-binding 
domains provided by incubation of DA 4% scaffolds in a 20 lg ml-1  hFN solution. 
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Fig.  6.  Cell  behaviour  of  HPMEC-ST1.6R  cells  on  CH  porous  conduits (DA  4%  and  DA  15%)  grafted  with  rhFNIII7–10.  (a)  Adhesion  of  HPMEC-ST1.6R  cells  as  a  function  of 
rhFNIII7–10  input concentration (mean ± SD; n = 6). Results corresponding to CH samples incubated in CCM or in a 20 lg ml-1  hFN solution are also shown. * indicates a 
signiﬁcant difference (p 6 0.05) from cell numbers found on DA 4% scaffolds incubated with hFN (dotted line). (b) Cytoskeleton organization of HPMEC-ST1.6R cells cultured 
on CH porous conduits grafted with rhFNIII7–10  (5, 10 and 20 lg ml-1), as shown by ﬂuorescent labelling of F-actin (green) and DNA (red). Cell cytoskeleton organization on 
conduits previously incubated in a 20 lg ml-1 hFN solution is also shown. Images obtained by CLSM, 24 h after cell seeding. Results show that concentrations of rhFNIII7–10 as 
low as 5 and 20 lg ml-1  were sufﬁcient to promote cytoskeletal rearrangement and cell spreading of EC adhered to CH with DA 4% and 15%, respectively. 
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15% for rhFNIII7–10 concentrations P20 lg ml-1. Under these graft- 
ing conditions (rhFNIII7–10 P 20 lg ml-1), cell adhesion on DA 15% 
was typically 1.4–1.7-fold higher than that provided by passively 
adsorbed hFN. In accordance with previous results, physiadsorbed 
hFN was much less effective in mediating EC adhesion to DA 15% 
compared with DA 4%. 
The effect of immobilized rhFNIII7–10 on EC cytoskeletal organi- 
zation was assessed after 24 h of cell culture. In line with    ﬂuorim- 
etry and cell adhesion results, F-actin/DNA labelling showed that 
rhFNIII7–10  concentrations of 5 and 20 lg ml-1  were sufﬁcient to 
promote  EC  cytoskeletal  rearrangement  on  CH  with  DA  4%  and 
15%, respectively (Fig. 6b). Under these grafting conditions, a 
homogeneous distribution of ECs over the inner surface of the por- 
ous conduits was achieved on both DAs. Higher  magniﬁcation 
CLSM images revealed ECs displaying diffuse F-actin distribution 
and preferentially oriented along the polymeric pore walls, simi- 
larly to those found on DA 4% scaffolds with physiadsorbed hFN 
(20 lg ml-1, control). 
Finally, the angiogenic potential of ECs seeded on the luminal 
surface of rhFNIII7–10-grafted CH porous scaffolds  was assessed. 
For this purpose, a ﬁbrin gel was added to the lumen of the EC- 
colonized scaffolds and cells cultured for 48 h in the presence of 
angiogenic inducers. At the end of this time, sprouting of viable 
ECs from the luminal surface of the scaffolds into the ﬁbrin gel 
was already visible under CLSM, as well as cell alignment and 
branching (Fig. 7a). Histology analysis of H&E-stained transversal 
cryosections also revealed cell migration from the EC-colonized 
scaffolds into the ﬁbrin gel, as well as the presence of ECs lining lu- 
men-like spaces, suggesting the formation of capillary-like struc- 
tures (Fig. 7b and c). On DA 4% conduits physiadsorbed with hFN 
(control), EC behaviour was similar to that described for rhFNIII7– 
10-grafted CH porous conduits (Fig.  S8). 
 
 
4. Discussion 
 
This study aimed to develop a strategy to efﬁciently promote EC 
adhesion to CH porous guidance matrices with different DAs. To 
achieve this goal, covalent binding of a recombinant fragment of 
human FN (rhFNIII7–10) was explored. Although lacking the multi- 
ple binding domains present in native hFN for extracellular matrix/ 
growth factor binding and self-assembly, rhFNIII7–10 has a smaller 
size than hFN (42 kDa vs. 440 kDa) [27], while presenting the hFN 
central cell binding domain with the RGD binding motif and the 
PHSRN synergy site. As a result, by using rhFNIII7–10 one can 
achieve higher surface densities of cell-binding domains when 
applying  similar  amounts  of  protein.  Moreover,  owing  to the 
presence of complementary domains and to its spatial conforma- 
tion, rhFNIII7–10 has advantages over short synthetic bioadhesive 
oligopeptides such as the RGD sequence, by conveying speciﬁcity 
towards a5b1 integrin and leading to higher cell activity both 
in  vitro  and  in  vivo  [37,38].  rhFNIII7–10    biospeciﬁcity    towards 
a5b1 integrin makes it an interesting ligand to mediate EC adhe- 
sion, as ECs use predominantly a5b1 integrin to adhere to hFN [39]. 
The porous conduits developed were tailored to bridge a 4 mm 
gap in an adult rat complete transection model of SCI (to be used in 
future in vivo evaluation of the pre-endothelialized scaffolds). 
Highly porous conduits with porous luminal surface were success- 
fully prepared from CH with DA 4% and 15%, using the moulding 
system described. For the desired application, a high and intercon- 
nected porosity is expected to be beneﬁcial for exchange of nutri- 
ents and oxygen with the surrounding tissue. Moreover, the open 
porosity of the luminal surface was shown to permit inﬁltration 
of an EC suspension into the spongy matrix (Fig. 7b and Fig. S8b), 
despite the smaller size of the interconnection pores. The DA 15% 
scaffolds showed a signiﬁcantly higher water uptake compared 
with DA 4% (also found for CH ﬁlms), which can be related to the 
decrease in CH crystallinity [16]. Despite the observed high water 
uptake, both type of scaffolds retained their original structure fol- 
lowing hydration. 
It was initially assessed whether passively adsorbed rhFNIII7–10 
was  able  to  mediate  EC  adhesion  to  CH.  Results  showed  that 
rhFNIII7–10  coating concentrations as low as 20 lg ml-1  were sufﬁ- 
cient to allow EC adhesion and subsequent cytoskeletal organiza- 
tion on DA 4%. However, pre-adsorption of rhFNIII7–10 was not 
able to mediate EC adhesion to DA 15%, regardless of the rhF- 
NIII7–10 concentration used. These marked differences in terms of 
EC behaviour correlated well with the lower amount of adsorbed 
rhFNIII7–10 and lower level of exposed cell-binding domains found 
on DA 15% compared with DA 4%, following the trend previously 
observed for the full hFN [20]. It is hypothesized that these differ- 
ences may be associated with the lower amount of amine groups 
(with concomitant increase of methyl groups) present on DA 15% 
compared with DA 4%. Surface chemistry was shown to modulate 
the amount and the conformation of adsorbed rhFNIII7–10, as well 
as its functional activity [40,41]. In particular, surfaces exposing 
amine groups were shown to promote rhFNIII7–10 adsorption and 
induce a more favourable conformation of adsorbed rhFNIII7–10 
for cell adhesion compared with COOH and CH3 groups, further 
supporting this assumption [40]. 
Covalent binding of rhFNIII7–10 to CH was then explored using 
EDC/NHS mediated amidation and 0.1 M MES as solvent. As 
expected, in the absence of EDC/NHS, minimal amounts of 
rhFNIII7–10  were detected on CH matrices, as shown by immunoﬂu- 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.  In vitro angiogenesis potential of HPMEC-ST1.6R cells cultured in CH porous conduits (DA 4%) grafted with rhFNIII7–10  (5 lg ml-1). ECs were seeded on the luminal 
surface of the porous conduits and cultured for 5 days. At this time point, a ﬁbrin gel was added, and cells were cultured for an additional period of 48 h in the presence of 
VEGF, bFGF and aprotinin. (a) CLSM imaging of hemisectioned conduits previously incubated with Calcein AM/propidium iodide shows sprouting of viable ECs (in green) from 
CH scaffolds into ﬁbrin. Cell alignment and branching was also observed (solid arrow). Cell migration of ECs into ﬁbrin was also revealed by H&E staining of transversal 
cryosections (b and c). Dashed arrow indicates EC lining a lumen-like space. 
  
orescent labelling of FN cell-binding domains. Dimethylformamide 
(DMF) was explored also for EDC/NHS coupling of rhFNIII7–10, as 
this solvent had been used previously by Ho and collaborators 
[42] for the grafting of RGD sequences to CH porous matrices. 
However, incubation in DMF resulted in large deposits of aggre- 
gated protein (results not shown), possibly due to rhFNIII7–10 lower 
solubility in DMF. Hence DMF was deferred in favour of 0.1 M MES. 
FTIR results suggest covalent binding of rhFNIII7–10 to CH primary 
amines. Following peptide grafting to CH amine groups, the most 
evident change expected in the FTIR spectrum of CH is a reduction 
in the absorbance of the N–H deformation peak in primary amines 
[42], which was observed. 
A linear increase of immobilized rhFNIII7–10 with increasing 
rhFNIII7–10 concentration was found, in contrast to the proﬁle of 
rhFNIII7–10 immobilization on two-dimensional surfaces, which 
usually presents a well-deﬁned saturation plateau [38]. This 
behaviour is attributed to the high surface area of the porous con- 
duits. Moreover, for the same rhFNIII7–10 concentration, higher 
amounts of immobilized rhFNIII7–10 and levels of exposed cell- 
binding domains were found on DA 4% compared with DA 15%. 
The higher grafting efﬁciency observed for DA 4% is possibly re- 
lated to the larger number of amine groups available for function- 
alization compared with those present in DA 15%. The 
immunoﬂuorescence bioactivity assays also showed that, for a spe- 
ciﬁc DA, the levels of exposed cell binding domains on CH can be 
tuned by varying the rhFNIII7–10 concentration in the coupling 
reaction. Speciﬁcally for DA 4% and 15% CH conduits, the lowest 
rhFNIII7–10 concentration required to achieve levels of exposed 
cell-binding domains similar to or  exceeding those provided   by 
passively  adsorbed  hFN  on  DA  4%  (positive  control)  was  5  and 
20 lg ml-1,  respectively.  These  same  rhFNIII7–10   concentrations 
were sufﬁcient to promote EC adhesion and cytoskeletal rearrange- 
ment on CH in the range of those observed in the control, in good 
agreement with the bioactivity levels found. Immobilized rhFNIII7– 
10 was shown, therefore, to be effective in mediating EC adhesion 
and cytoskeleton organization on CH, which are two key cellular 
events required for EC proliferation and the establishment of 
cell–cell contacts, ultimately leading to the formation of a func- 
tional EC layer in vivo. A minimum density of hFN cell-binding epi- 
topes is required for integrin clustering, focal adhesion assembly 
and actin polymerization [43]. Therefore, one may assume that 
rhFNIII7–10 covalent binding was able to provide this minimum 
density of cell-binding domains to CH with DA 4% and 15%, and 
that the minimal rhFNIII7–10 input concentration is dependent on 
the DA. Finally, the in vitro angiogenic potential of ECs seeded on 
rhFNIII7–10-functionalized CH conduits was evaluated. Results 
showed that, besides efﬁciently mediating EC adhesion and cyto- 
skeletal rearrangement on CH, immobilized rhFNIII7–10 does not 
interfere with EC ability to sprout and form capillary-like struc- 
tures following the addition of a ﬁbrin gel to the inner lumen of 
the scaffolds. This EC feature will be essential for the establishment 
of a functional microvascular network following implantation of 
the pre-endothelialized conduits in vivo. 
In summary, the present results demonstrate that grafting of 
rhFNIII7–10 can be used as a strategy to endothelialize the luminal 
surface of porous CH conduits with different DAs. To the best of the 
present authors’ knowledge, this is the ﬁrst report exploring the 
use of this bioadhesive ligand to promote the endothelialization 
of porous polymeric structures. This endothelialized conduit is ex- 
pected to contribute to angiogenesis and to the formation in vivo of 
a vascular network within the scaffold, which will be beneﬁcial to 
the survival of the graft following implantation in an SCI. Also, 
when used as a vehicle for the transplantation of relevant cell types 
in the context of SCI therapies, pre-endothelialized conduits are ex- 
pected to contribute to the survival of the transplanted cells. In this 
manner, endothelialized porous conduits are expected to  impact 
the outcome of cell transplantation therapies in the spinal cord, 
ultimately leading to long-distance axonal regeneration and im- 
proved functional recovery. This hypothesis is currently being 
investigated  by the authors’team. 
 
5. Conclusions 
 
CH porous conduits with porous luminal surface were success- 
fully prepared by TIPS for application in spinal cord regenerative 
therapies. To promote EC adhesion to CH with different DAs, cova- 
lent binding of rhFNIII7–10 was explored. The results demonstrate 
that the amount and levels of exposed cell-binding domains of 
immobilized rhFNIII7–10 can be tuned by varying the rhFNIII7–10 
concentration in the coupling reaction. Moreover, these parame- 
ters were found to be DA-dependent. Finally, it was shown that 
rhFNIII7–10  concentrations  as  low  as  5  and  20 lg ml-1  efﬁciently 
mediated EC adhesion and cytoskeletal rearrangement on CH with 
DA 4% and 15%, respectively, without affecting the endothelial 
angiogenic  potential,  a  fundamental   feature   for  angiogenesis 
in vivo. Taken together, these results demonstrate that grafting of 
rhFNIII7–10 can be used as a strategy to endothelialize CH porous 
scaffolds with different DAs, this being of particular interest when 
matrices with different degradation rates are   required. 
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Appendix A. Figures with essential color discrimination 
 
Certain ﬁgures in this article, particularly Figs. 2, 5–7, are difﬁ- 
cult to interpret in black and white. The full color images can be 
found in the on-line version, at http://dx.doi.org/10.1016/j.actbio. 
2012.10.029. 
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Supplementary data associated with this article can be found, in 
the online version, at http://dx.doi.org/10.1016/j.actbio.2012.10. 
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